NanoViricides is a biotechnology business based in the US. NanoViricides shares (NNVC) are listed on the NYSE MKT and all prices are listed in US Dollars. NanoViricides employs 17 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy NanoViricides stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – NNVC. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
NanoViricides stock price (NYSE MKT: NNVC)
Use our graph to track the performance of NNVC stocks over time.NanoViricides shares at a glance
Latest market close | $1.45 |
---|---|
52-week range | $1.04 - $3.88 |
50-day moving average | $1.45 |
200-day moving average | $1.82 |
Wall St. target price | $8.50 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.73 |
Buy NanoViricides stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy NanoViricides stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
NanoViricides price performance over time
Historical closes compared with the close of $1.45 from 2023-01-26
1 week (2023-01-20) | 3.57% |
---|---|
1 month (2022-12-27) | 28.32% |
3 months (2022-10-28) | -12.12% |
6 months (2022-07-28) | -20.33% |
1 year (2022-01-28) | -32.87% |
---|---|
2 years (2021-01-28) | -61.33% |
3 years (2020-01-28) | 8.4 |
5 years (2018-01-26) | 46.42% |
NanoViricides financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -17.37% |
Return on equity TTM | -28.33% |
Profit margin | 0% |
Book value | $1.86 |
Market capitalisation | $16.4 million |
TTM: trailing 12 months
NanoViricides share dividends
We're not expecting NanoViricides to pay a dividend over the next 12 months.
Have NanoViricides's shares ever split?
NanoViricides's shares were split on a 1:20 basis on 23 September 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NanoViricides shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for NanoViricides shares which in turn could have impacted NanoViricides's share price.
NanoViricides share price volatility
Over the last 12 months, NanoViricides's shares have ranged in value from as little as $1.04 up to $3.88. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while NanoViricides's is 1.068. This would suggest that NanoViricides's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
NanoViricides overview
NanoViricides, Inc. , a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Monkeypox Treatment for Monkeypox virus; Adenovirus 71 Treatment for severe pediatric hepatitis caused by Adenovirus 71 or related viruses; and HerpeCide Program Expansion Drug project that develops broad-spectrum nanoviricide drugs against different herpes viruses for different indications. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. The company was founded in 2005 and is based in Shelton, Connecticut. .
Frequently asked questions
What percentage of NanoViricides is owned by insiders or institutions?Currently 4.4% of NanoViricides shares are held by insiders and 11.334% by institutions. How many people work for NanoViricides?
Latest data suggests 17 work at NanoViricides. When does the fiscal year end for NanoViricides?
NanoViricides's fiscal year ends in June. Where is NanoViricides based?
NanoViricides's address is: 1 Controls Drive, Shelton, CT, United States, 06484 What is NanoViricides's ISIN number?
NanoViricides's international securities identification number is: US6300873022 What is NanoViricides's CUSIP number?
NanoViricides's Committee on Uniform Securities Identification Procedures number is: 630087302
More guides on Finder
-
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert